← FDA DRUG APPROVALS

FDA ANDA · ANDA080256

METHYLTESTOSTERONE

Sponsor: LILLY

APPLICATION
ANDA080256
TYPE
ANDA
ORIGINAL APPROVAL
1971-12-22
LATEST ACTION
1971-12-22
ROUTE
BUCCAL, SUBLINGUAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

METHYLTESTOSTERONEDiscontinued
METHYLTESTOSTERONE 25MG · TABLET · BUCCAL, SUBLINGUAL
METHYLTESTOSTERONEDiscontinued
METHYLTESTOSTERONE 10MG · TABLET · BUCCAL, SUBLINGUAL

Approval history

1971-12-22OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →